Table 3. Reference range of T lymphocyte subsets in different gender.
| Male | Female | ||||
|---|---|---|---|---|---|
| Parameters | Mean ±SD | 95%CI | Mean ±SD | 95%CI | p value(M&F) |
| CD19+ B counts (cells/ul) | 223.5±105.40 | 129.95-315.75 | 215.7±98.45 | 121.31-276.50 | 0.001 |
| CD19+ B percentage (%) | 10.2±3.63 | 6.55-13.84 | 10.3±3.59 | 7.13-14.20 | 0.031 |
| CD16+CD56+ NK counts(cells/ul) | 448.0±223.25 | 244.49-650.87 | 407.5±216.91 | 160.72-470.68 | <0.001 |
| CD16+CD56+ NK percentage (%) | 20.4±8.33 | 12.20-28.81 | 19.3±8.21 | 9.62-23.73 | <0.001 |
| CD3+ T counts (cells/ul) | 1438.6±418.98 | 1031.80-1845.75 | 1394.0±417.15 | 916.46-1672.80 | <0.001 |
| CD3+ T percentage (%) | 65.4±8.57 | 56.55-74.40 | 66.4±8.39 | 60.62-76.35 | <0.001 |
| CD3+CD4+ counts (cells/ul) | 696.0±232.80 | 478.02-912.79 | 688.2±228.78 | 466.85-874.61 | 0.139 |
| CD3+CD4+/CD3+ (%) | 31.8±6.83 | 24.88-38.74 | 33.0±6.94 | 29.21-42.21 | <0.001 |
| CD3+CD8+ counts (cells/ul) | 631.1±254.60 | 389.50-873.19 | 597.5±246.38 | 328.11-716.92 | <0.001 |
| CD3+CD8+/CD3+ (%) | 28.5±7.92 | 20.64-36.40 | 28.2±7.60 | 20.70-34.31 | 0.125 |
| CD4+CD45RA− (cells/ul) | 429.0±156.34 | 286.61-570.10 | 424.6±150.57 | 289.36-541.15 | 0.347 |
| CD4+CD45RA−/CD4+ (%) | 62.3±11.53 | 50.07-74.79 | 62.5±11.50 | 51.16-74.96 | 0.390 |
| CD4+CD45RA+ (cells/ul) | 267.0±133.68 | 142.48-391.46 | 263.6±134.54 | 133.24-377.01 | 0.143 |
| CD4+CD45RA+/CD4+ (%) | 37.7±11.53 | 25.61-49.91 | 37.5±11.50 | 25.04-49.13 | 0.413 |
| CD4+CD45RA+CD62L+ (cells/ul) | 242.8±124.86 | 126.60-359.19 | 240.0±126.47 | 117.93-347.58 | 0.160 |
| CD4+CD45RA+CD62L+/CD4+ (%) | 34.4±11.48 | 22.26-46.82 | 34.2±11.45 | 21.95-45.72 | 0.470 |
| CD4+CD28+ (cells/ul) | 616.5±204.90 | 423.33-808.88 | 611.5±205.14 | 410.02-790.52 | 0.228 |
| CD4+CD28+/CD4+ (%) | 89.1±8.38 | 79.76-98.40 | 89.2±8.16 | 80.89-98.14 | 0.425 |
| CD8+CD28+ (cells/ul) | 349.9±132.85 | 221.31-479.19 | 336.0±130.06 | 189.24-422.56 | <0.001 |
| CD8+CD28+/CD8+ (%) | 57.7±14.01 | 43.00-72.51 | 58.4±13.80 | 45.18-75.25 | 0.017 |
| CD8+HLA-DR (cells/ul) | 147.3±102.74 | 58.20-236.70 | 138.0±99.20 | 47.78-184.00 | <0.001 |
| CD8+HLA-DR/CD8+ (%) | 22.7±10.74 | 11.94-33.92 | 22.4±10.72 | 11.65-32.10 | 0.267 |
| CD8+CD38+ (cells/ul) | 191.6±111.9 | 99.28-280.28 | 190.0±108.43 | 95.84-277.46 | 0.535 |
| CD8+CD38+/CD8+ (%) | 31.2±13.16 | 18.91-43.27 | 32.7±13.74 | 22.61-50.00 | 0.552 |
| CD4+/CD8+ ratio (%) | 1.2±0.54 | 0.75-1.71 | 1.3±0.54 | 0.93-1.87 | <0.001 |